Surendra K. Ajjarapu - 22 Jun 2026 Form 4 Insider Report for Wellgistics Health, Inc. (WGRX)

Reporting relationship: Director
Issuer ticker: WGRX
Reported as of: 22 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 25 Jun 2026, 16:59:18 UTC
Prior SEC filing: 25 Jun 2026
Next SEC filing: 24 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Surendra K Ajjarapu

Key filing fact

Surendra K. Ajjarapu filed Form 4 for Wellgistics Health, Inc. (WGRX) on 25 Jun 2026.

Key facts

This page summarizes Surendra K. Ajjarapu's Form 4 filing for Wellgistics Health, Inc. (WGRX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 25 Jun 2026, 16:59.

Change

Previous filing in this sequence was filed on 25 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001368298 Primary reporting owner

AJJARAPU SURENDRA K

Relationship: Director
Address: C/O WELLGISTICS HEALTH, INC., 3000 BAYPORT DRIVE, SUITE 950, TAMPA,
Signature: /s/ Surendra K Ajjarapu
Signature date: 25 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WGRX transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares: +100,000
Change %: +63%
Price: $0.005000^*
Shares after: 257,645
Date: 22 Jun 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

WGRX transaction Derivative

Warrant

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares: +100,000
Change %
Price: $0.000000^*
Shares after: 0
Date: 22 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $0.005000

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the conversion of warrants (the "Warrants") issued to the Reporting Person on 3/31/2026 in lieu of cash compensation due to the Reporting Person.

Footnote F2

Reflects the aggregate amount of Common Stock held by the Reporting Person following the Issuer's reverse stock split, effective May 26, 2026, as well as the Common Stock issued pursuant to the conversion of the Warrants.